CCND1 and neoplasm: Apart from the role as a prognostic marker, cyclin D1 has been proposed as a predictive factor for tamoxifen response, as illustrated by poor clinical outcome in patients with ER-positive tumours with high cyclin D1 expression treated with tamoxifen [46].